Medicare Enrolled
Dr. Andrew Simpson, MD
Gastroenterology · Decatur, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Simpson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Simpson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Simpson
Dr. Andrew Simpson is a gastroenterology specialist in Decatur, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Simpson performed 472 Medicare services across 399 unique beneficiaries.
Between the years covered by Open Payments, Dr. Simpson received a total of $8,949 from 52 pharmaceutical and/or device companies across 510 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Simpson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ 472 Medicare services
$8,949 industry payments
Medicare Practice Summary
Medicare Utilization ↗472
Medicare services
Bottom 38% in GA for gastroenterology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
399
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~26 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
151 | $87 | $310 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
64 | $83 | $615 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $62 | $305 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $115 | $400 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
34 | $110 | $798 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
30 | $208 | $1,028 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
27 | $62 | $190 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $102 | $316 |
| Dilation of esophagus | 14 | $32 | $200 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
14 | $180 | $725 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
12 | $180 | $725 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
11 | $137 | $725 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,949
Total received (2018-2024)
Avg $1,278/year across 7 years
Top 19% in GA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
510
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,888 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$61 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,616
2023
$1,367
2022
$718
2021
$1,138
2020
$906
2019
$916
2018
$1,288
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$451
ABBVIE INC.
$386
Lilly USA, LLC
$264
Regeneron Healthcare Solutions, Inc.
$232
Takeda Pharmaceuticals U.S.A., Inc.
$209
Intercept Pharmaceuticals, Inc.
$154
Phathom Pharmaceuticals, Inc.
$105
Gilead Sciences, Inc.
$92
Celgene Corporation
$92
GENZYME CORPORATION
$90
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$80
Ardelyx, Inc.
$74
PFIZER INC.
$42
Ipsen Biopharmaceuticals, Inc
$41
Organon Llc
$40
Celltrion USA Inc.
$39
AIMMUNE THERAPEUTICS, INC.
$33
Madrigal Pharmaceuticals
$30
QOL Medical, LLC
$25
Braintree Laboratories, Inc.
$23
Fresenius Kabi USA, LLC
$21
Tempus AI, Inc
$21
Merck Sharp & Dohme LLC
$21
IRONWOOD PHARMACEUTICALS, INC
$20
RedHill Biopharma Inc.
$17
Ferring Pharmaceuticals Inc.
$13
Top 3 companies account for 42.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,255
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,092
AbbVie Inc.
$828
Takeda Pharmaceuticals U.S.A., Inc.
$657
ABBVIE INC.
$597
Romark Laboratories, LC
$361
Lilly USA, LLC
$322
Gilead Sciences, Inc.
$309
Regeneron Healthcare Solutions, Inc.
$285
AbbVie, Inc.
$272
Daiichi Sankyo Inc.
$254
Merck Sharp & Dohme Corporation
$225
Intercept Pharmaceuticals, Inc.
$215
Celgene Corporation
$172
PFIZER INC.
$158
GENZYME CORPORATION
$130
Merck Sharp & Dohme LLC
$125
INTERCEPT PHARMACEUTICALS, INC.
$115
Ardelyx, Inc.
$112
Phathom Pharmaceuticals, Inc.
$105
Ironwood Pharmaceuticals, Inc
$102
UCB, Inc.
$101
AMAG Pharmaceuticals, Inc.
$76
RedHill Biopharma Inc.
$73
Amgen Inc.
$67
Covidien LP
$66
CSL Behring
$60
Synergy Pharmaceuticals Inc
$59
Ferring Pharmaceuticals Inc.
$53
IRONWOOD PHARMACEUTICALS, INC
$51
Shionogi Inc
$46
Alfasigma USA, Inc.
$43
Ipsen Biopharmaceuticals, Inc
$41
Organon Llc
$40
Celltrion USA Inc.
$39
Otsuka America Pharmaceutical, Inc.
$38
Fresenius Kabi USA, LLC
$37
Xeris Pharmaceuticals, Inc.
$37
Braintree Laboratories, Inc.
$37
Allergan Inc.
$36
Nestle HealthCare Nutrition Inc.
$35
Endo Pharmaceuticals Inc.
$34
AIMMUNE THERAPEUTICS, INC.
$33
Madrigal Pharmaceuticals
$30
QOL Medical, LLC
$25
Biogen, Inc.
$22
Tempus AI, Inc
$21
CapsoVision, Inc.
$17
Novo Nordisk Inc
$15
Shire North American Group Inc
$15
INTRA-SANA LABORATORIES
$5
Napo Pharmaceuticals Inc
$5
Top 3 companies account for 35.5% of all-time payments
Associated products mentioned in payments ›
ALINIA · AMJEVITA · AVSOLA · Aemcolo · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · BREATHTEK · CLENPIQ · CREON · CapsoCam Plus · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · Entyvio · Epclusa · FERAHEME · GATTEX · HUMIRA · Humira · IBSRELA · IDACIO · INJECTAFER · IQIRVO · KEVEYIS · Kcentra · LINZESS · Linzess · MAVYRET · MAXAIR · MOTEGRITY · MOVIPREP · Manometry · Morphabond ER · Motegrity · Mulpleta · Mytesi · NASCOBAL · OCALIVA · OMVOH · PLENVU · REBYOTA · RELISTOR · RELTONE 200 MG · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · SPINRAZA · STELARA · SUCRAID · SUFLAVE · SUPREP · Saxenda · Symproic · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · UCERIS TABLETS · VEGZELMA · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPATIER · ZEPOSIA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
223
Per 100K population
29.3
County median income
$77,683
Nearest hospital
EMORY DECATUR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Simpson is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 19% of GA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Simpson experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Simpson performed 151 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Simpson receive payments from pharmaceutical companies?
Yes. Dr. Simpson received a total of $8,949 from 52 companies across 510 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Simpson's costs compare to other gastroenterologists in Decatur?
Dr. Simpson's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Simpson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Decatur
Browse gastroenterologists in Decatur ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in GA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in GA
Which GA gastroenterologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology